Related Experiment Video
Updated: Aug 3, 2026

Toxin Induction and Protein Extraction from Fusarium spp. Cultures for Proteomic Studies
Published on: February 16, 2010
Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice
K A Voss1, R T Riley, C W Bacon
1Richard B. Russell Agricultural Research Center, USDA, Athens, Georgia 30604-5677, USA.
Abstract:
Fumonisins are mycotoxins produced by the fungi Fusarium moniliforme, F. proliferatum, and other Fusarium species. Fumonisin B1, the most commonly found fumonisin, causes the fatal diseases equine leukoencephalomalacia and porcine pulmonary edema. Fumonisins are suspected human carcinogens because of the extraordinarily high incidences of esophageal cancer coincidentally found in areas of southern Africa and China where F. moniliforme-contaminated corn is consumed as a dietary staple. The subchronic (up to 90 days) effects of F. moniliforme-contaminated corn, corn cultures of this fungus, and purified fumonisin B1 (FB1) in rats and mice were systematically studied to determine target organs, characterize organ-specified lesions, and obtain dose-response data. The liver is a target organ in both species. Serum chemical findings indicative of hepatocellular injury and morphological findings, including apoptosis, appeared qualitatively similar in both species. The kidney is also a target organ in rats, but not mice. Lesions which include apoptosis and cellular degeneration are predominately found in the outer medella. Results of several investigations showed that the kidney was consistently affected at lower doses than the liver. The "no-observed-effect" level for nephropathy in rats was also consistently lower in males than females, suggesting a sex-related difference in nephrotoxic response to fumonisins. Other findings suggest that toxigenesis may be mediated by disruption of de novo sphingolipid biosynthesis. Hepatic and renal sphingolipid profiles, specifically sphinganine concentration and sphinganine-to-sphingosine ratio, were altered in rats fed FB1 at levels that did not cause serum chemical, organ weight, or histopathological evidence of toxicity.
Insights
Fumonisins, mycotoxins from Fusarium fungi, cause liver and kidney damage in rats and mice. Fumonisin B1 exposure disrupts sphingolipid biosynthesis, impacting animal health and raising human cancer concerns.
Area of Science:
- Toxicology
- Mycotoxicology
- Animal Health
Background:
- Fumonisins are mycotoxins produced by Fusarium species, notably Fusarium moniliforme.
- Fumonisin B1 (FB1) is linked to equine leukoencephalomalacia and porcine pulmonary edema.
- High esophageal cancer rates in some regions correlate with consumption of FB1-contaminated corn.
Purpose of the Study:
- To determine target organs and dose-response data for subchronic fumonisin exposure in rats and mice.
- To characterize organ-specific lesions caused by fumonisins.
- To investigate the role of sphingolipid biosynthesis disruption in fumonisin toxicity.
Main Methods:
- Subchronic (90-day) administration of Fusarium moniliforme-contaminated corn, corn cultures, and purified Fumonisin B1 (FB1) to rats and mice.
- Assessment of serum chemistry, organ weights, histopathology, and sphingolipid profiles.
- Dose-response analysis to establish no-observed-effect levels (NOELs).
Main Results:
- The liver was identified as a target organ in both rats and mice, showing hepatocellular injury and apoptosis.
- The kidney was a target organ in rats, with lesions in the outer medulla, affected at lower doses than the liver.
- A sex-related difference in nephrotoxic response was observed in male rats compared to females.
- FB1 exposure altered hepatic and renal sphingolipid profiles, increasing sphinganine and the sphinganine-to-sphingosine ratio, even at non-toxic doses.
Conclusions:
- Fumonisins target the liver and kidneys, with varying sensitivity between species and sexes.
- Disruption of sphingolipid biosynthesis is a key mechanism of fumonisin toxicity.
- FB1 poses a significant health risk, necessitating further investigation into its carcinogenic potential and effects on animal and human health.

